Home About Us Participants Study Opportunities Sponsors Contact Us Become a Study Member

A participant story: Deb

"Participating in this clinical study made me realize that it's possible to live pain-free."
- Deb Geiss View Deb's story


Since 1999, MARC has conducted over 100 trials across a wide range of therapeutic areas including: Pain Management (Acute, Chronic and Interventional), Neurology, Gastrointestinal, Muscular/Skeletal, Dermatology, Mental Health, Cardiovascular, Endocrinology/Metabolic, Sleep Medicine, Bone and Joint Disease, Infectious Disease, Autoimmune Disease, Women’s Health, Nutraceuticals and Pharmacokinetics.

Previous studies

Click on the dates below to view our previous studies.

2009

"A Phase 3 Randomized, Double-Blind, Placebo and Naproxen Controlled Multi-Center Study of the Analgesic Efficacy and Safety of Tanezumab in Patients with Osteoarthritis of the Knee."

"A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Subcutaneous MOA-728 for the Treatment of Opioid-Induced Constipation."

"An Open–Label Study to Evaluate the Long-term Safety of Subcutaneous MOA-728 for Treatment of Opioid-Induced Constipation in Subjects with Nonmalignant Pain."

"Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy."

2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
Home | About Us | Participants | Study Opportunities | Sponsors | Facility | Careers | Links| Newsletter | Contact Us
Any information shared by you to MARC on this website is considered confidential and will not be disclosed to anyone.